Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 90,043 | 56,157 | 50,465 | 33,375 | 27,995 |
| Cost of Goods | 1,134 | 788 | 1,737 | 2,385 | 903 |
| Gross Profit | 88,909 | 55,369 | 48,728 | 30,990 | 27,092 |
| Operating Expenses | 18,868 | 19,116 | 21,113 | 14,882 | 14,980 |
| Operating Income | 70,175 | 37,041 | 28,352 | 16,493 | 13,015 |
| Interest Expense | 13,454 | 3,480 | 3,792 | 3,386 | 3,341 |
| Other Income | 38,858 | 21,751 | 6,107 | -1,036 | -1,374 |
| Pre-tax Income | 95,579 | 55,312 | 30,667 | 12,071 | 8,300 |
| Income Tax | 22,419 | 10,033 | 37,674 | 3,645 | 2,242 |
| Net Income Continuous | 73,160 | 45,279 | -7,007 | 8,426 | 6,058 |
| Net Income | $73,160 | $45,279 | $-7,007 | $8,426 | $6,058 |
| EPS Basic Total Ops | 3.45 | 2.13 | -0.33 | 0.40 | 0.29 |
| EPS Basic Continuous Ops | 3.45 | 2.13 | -0.33 | 0.40 | 0.29 |
| EPS Diluted Total Ops | 2.99 | 1.83 | -0.31 | 0.36 | 0.26 |
| EPS Diluted Continuous Ops | 2.99 | 1.83 | -0.30 | 0.36 | 0.26 |
| EBITDA(a) | $84,473 | $43,061 | $35,376 | $21,437 | $18,482 |